[1] SIEGEL R, DESANTIS C, VIRGO K, et al.Cancer treatment and survivorship statistics,2012[J].CA Cancer J Clin,2012,62(4):220-241. [2] HOFFMAN B L, SCHORGE J O, SCHAFFER J I, et al.Williams gynecology[M]. New York:McGraw-Hill,2012:817-838. [3] TAVASSOLI F A, DEVILEE P. Pathology and genetics of tumours of the breast and female genital organs[J].IARC,2003,78(1):398-399. [4] KURMAN R J, CARCANGIU M L, HERRINGTON C S, et al. WHO classification of tumours of female reproductive organs[M].4 ed.Lyon:World Health Organization,2014:132-133. [5] SILVA E G, DEAVERS M T, BODURKA D C, et al. Association of low-grade endometrioid carcinoma of the uterus and ovary with undifferentiated carcinoma:a new type of dedifferentiated carcinoma?[J].Int J Gynecol Pathol,2006,25(1):52-58. [6] SILVA E G, DEAVERS M T, MALPICA A. Undifferentiated carcinoma of the endometrium:a review[J].Pathology,2007,39(1):134-138. [7] GARG K,SHIH K,BARAKAT R,et al.Endometrial carcionomas in women aged 40years and younger:tumors associated with loss of DNA mismatch repair proteins comprise a distinct clinicopathologic subset[J].AM J Surg Pathol,2009,33(12):1869-1877. [8] RAMALINGAM P, MASAND R, EUSCHER E D,et al. Undifferentiated carcinoma of the endometrium:an expanded immunohistochemical analysis including PAX-8 and basal-like carcinoma surrogate markers[J].Int J Gynecol Pathol,2016,35(5):410-418. [9] SAAD R S, MASSHOUR M, NOFTECH-MOZES S,et al.p16 expression in undifferentiated carcinoma of the uterus does not exclude its endometrial origin[J].Int J Gynecol Pathol,2012,31(1):57-65. [10] YEMELYANOVA A, GOWN A M, WU L S, et al. PAX8 expression in uterine adenocarcinomas and mesonephric proliferations[J].Int J Gynecol Pathol,2014,33(5):492-499. [11] LAURY A R, PERETS R, PIAO H, et al. A comprehensive analysis of PAX8 expression in human epithelial tumors[J].Am J Surg Pathol,2011,35(6):816-826. [12] PARK S Y, PARK M H, KO H S, et al. Dedifferentiated endometrioid adenocarcinoma of the uterus:highly aggressive and poor prognostic tumor[J]. Korean J Pathol,2014,48(4):327-330. [13] LI Z, ZHAO C. Clinicopathologic and immunohistochemical characterization of dedifferentiated endometrioid adenocarcinoma[J].Appl Immunohistochem Mol Morphol,2016,24(8):562-568. [14] TAFE L J, GARG K, CHEW I, et al.Endometrical and ovarian carcinomas with undifferentiated components:clinical aggressive and frequently underrecognized neoplasms[J].Mod Pathol,2010,23(6):781-789. [15] 王昀,晋薇,宋欣,等.子宫内膜未分化及去分化癌8例临床病理特点[J].诊断病理学杂志,2017,24(4):252-257. [16] KAZU U, KYOSUKE Y, MITSUYOSHI U, et al. Association of extracellular matrix metalloproteinase inducer in endometrial carcinoma with patient outcomes andclinicopathogenesis using monoclonal antibody 12C3[J].Oncol Rep, 2007,17(4):731-735. [17] BERRETTA R, PATRELLI T S, FAIOLI R, et al. Dedifferentiated endometrial cancer:An atypical case diagnosed from cerebellar and adrenal metastasis:Case presentation and review of literature[J].Int J Clin Exp Pathol, 2013,6(8):1652-1657. [18] ALTRABULSI B, MALPICA A, BODURKA D C, et al.Undifferentiated carcinoma of the endometrium[J].Am J Surg Pathol,2005,29(10):1316-1321. |